NASDAQ
InMed Pharmaceuticals Inc. (INM) has a fcf yield of -244.86% as of Friday, May 29, 2026. This represents a 85.31% increase compared to its 12-month average of -1667.31%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.